Sep 2, 2019 02:00AM
Aug 19, 2019 02:00AM
Aug 1, 2019 02:00AM
Jul 26, 2019 06:23AM
Jul 26, 2019 02:00AM
Jul 26, 2019 02:00AM
Jul 19, 2019 02:00AM Motif Bio Announces Receipt of Deficiency Notice from Nasdaq
Jul 15, 2019 02:00AM
Jun 24, 2019 02:00AM
Jun 6, 2019 06:16AM
Jun 6, 2019 02:00AM
May 31, 2019 10:15AM
May 22, 2019 08:50AM
May 22, 2019 02:00AM Motif Bio to Evaluate Orphan Disease Opportunity for Iclaprim in Ophthalmology
May 21, 2019 02:00AM
May 3, 2019 01:25PM
May 1, 2019 02:00AM
Apr 26, 2019 05:45AM
Apr 26, 2019 02:01AM
Apr 26, 2019 02:00AM
Apr 16, 2019 02:00AM Motif Bio Presents New Iclaprim Data at ECCMID 2019
Apr 15, 2019 02:00AM
Apr 4, 2019 02:00AM
Mar 20, 2019 09:34AM
Mar 20, 2019 06:16AM
Mar 20, 2019 03:00AM
Mar 18, 2019 05:54AM
Mar 18, 2019 03:00AM Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the Board
Feb 19, 2019 02:00AM
Feb 18, 2019 02:00AM
Feb 14, 2019 05:59AM
Feb 14, 2019 02:00AM
Oct 31, 2018 03:00AM
Oct 3, 2018 03:01AM
Sep 25, 2018 02:00AM Motif Bio Reports Half-Year 2018 Financial Results and Operational Progress
Sep 20, 2018 02:00AM
Sep 5, 2018 02:00AM
Aug 17, 2018 02:00AM
Aug 14, 2018 06:26AM
Aug 14, 2018 02:00AM
Aug 9, 2018 02:00AM
Aug 8, 2018 02:00AM Motif Bio Announces Notice of Allowance for Two U.S. Iclaprim Patents with Expiration in 2037
Jul 3, 2018 05:49AM
Jul 3, 2018 02:00AM
Jun 19, 2018 10:00AM
Jun 14, 2018 06:25AM
Jun 14, 2018 02:00AM
Jun 11, 2018 02:00AM
May 31, 2018 02:00AM Motif Bio to present at Jefferies Global Healthcare Conference in New York
May 9, 2018 02:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All